粉笔
发表于 2025-3-25 05:24:40
https://doi.org/10.1007/978-981-32-9127-0thromboprophylaxis in patients with non-valvular atrial fibrillation (NVAF) and for the treatment and prevention of venous thromboembolism (VTE). In patients with multiple conditions, as in particular NVAF ones or with cancer, the contemporary administration of several drugs can cause relevant drug–
mighty
发表于 2025-3-25 08:35:18
The Community Street Soccer Programr Xa inhibitors (rivaroxaban, apixaban, edoxaban, betrixaban). They have largely replaced vitamin K anticoagulants (VKAs) in clinical practice. Their overall safety profile concerning bleeding appears to be at least equivalent, if not superior, to VKAs. However, the lack of a specific reversal agent
SEEK
发表于 2025-3-25 12:01:28
https://doi.org/10.1007/978-1-4614-5996-5ant agents play a key role in preventing this complication. Through years, several risk stratification algorithms have been investigated, while others are still object of debate. According to current guidelines, CHA2DS2VASc score and HAS-BLED score are the ones suggested for stroke and bleeding risk
Reservation
发表于 2025-3-25 16:29:23
William J. Moreau,Dustin Nabhanmorrhagic events are increased in patients with kidney disease. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic stroke prevention in high-risk patients. However, all four available DOACs (dabigatran, apixaban, rivarox
extemporaneous
发表于 2025-3-25 22:12:35
http://reply.papertrans.cn/29/2807/280625/280625_25.png
acolyte
发表于 2025-3-26 03:46:07
Brenden J. Balcik,Aaron J. Monseauovascular (CV) risk, more and more evidences suggest a favorable prognosis in obese subjects with cardiovascular disease (CVD), a phenomenon known as “obesity paradox.” Obesity paradox has been demonstrated in various CVD including atrial fibrillation (AF) and venous thromboembolism (VTE) for which
bronchodilator
发表于 2025-3-26 06:57:18
https://doi.org/10.1007/978-3-030-36790-9thromboembolism is a leading cause of mortality, especially in patients undergoing chemotherapy. The anticoagulant strategy to be administered in these cases is particularly difficult to choose due to an altered state of coagulation that makes the balance between hypercoagulation and bleeding risk i
神化怪物
发表于 2025-3-26 12:02:28
http://reply.papertrans.cn/29/2807/280625/280625_28.png
思考才皱眉
发表于 2025-3-26 14:24:55
http://reply.papertrans.cn/29/2807/280625/280625_29.png
companion
发表于 2025-3-26 18:58:51
http://reply.papertrans.cn/29/2807/280625/280625_30.png